Press Releases InMed Pharmaceuticals Reports First Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update November 12, 2018 Read More » InMed Pharmaceuticals to Report First Quarter Fiscal 2019 Financial Results and Business Update on November 12, 2018 November 5, 2018 Read More » InMed Pharmaceuticals Appoints Michael Woudenberg as Vice President, Chemistry, Manufacturing, and Controls November 5, 2018 Read More » InMed Pharmaceuticals to Present at BIO Investor Forum on October 17, 2018 October 10, 2018 Read More » InMed Pharmaceuticals Signs Agreement with the National Research Council of Canada for Cannabinoid Biofermentation Process Development and Scale-Up October 3, 2018 Read More » InMed Pharmaceuticals Files PCT Patent Application for the Treatment of Pain with Cannabinoids September 25, 2018 Read More » InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update September 13, 2018 Read More » InMed Pharmaceuticals Announces NSERC Grant to The University of British Columbia in Support of Collaborative R&D Work September 11, 2018 Read More » InMed Files Patent Application for its Cannabinoid Biosynthesis Program September 10, 2018 Read More » InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2018 Financial Results and Business Update on September 13, 2018 September 7, 2018 Read More » InMed Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference August 31, 2018 Read More » InMed to Present at the Canaccord Genuity 38th Annual Growth Conference August 1, 2018 Read More » InMed Pharmaceuticals Announces the Closing of C$14.95 Million Bought Deal Financing including Full Exercise of Underwriter’s Over-Allotment Option June 21, 2018 Read More » InMed to Present at the 8th Annual LD Micro Invitational Conference May 29, 2018 Read More » InMed Files Patent Application for INM-085 Glaucoma Program May 14, 2018 Read More » InMed Reports Third Quarter Fiscal 2018 Financial Results and Business Updates May 11, 2018 Read More » InMed Appoints Dr. Vikramaditya G. Yadav to Scientific Advisory Board May 1, 2018 Read More » InMed Rings the Opening Bell at the Toronto Stock Exchange April 17, 2018 Read More » InMed Announces Appointment of Joshua Blacher as Chief Business Officer April 11, 2018 Read More » InMed Pharmaceuticals Announces Graduation to Toronto Stock Exchange March 23, 2018 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Next » Management Learn More Board of Directors Learn More Scientific Advisory Board Learn More Investor Alerts Sign up to receive news releases from InMed Pharmaceuticals. SIGN UP
InMed Pharmaceuticals Reports First Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update November 12, 2018 Read More »
InMed Pharmaceuticals to Report First Quarter Fiscal 2019 Financial Results and Business Update on November 12, 2018 November 5, 2018 Read More »
InMed Pharmaceuticals Appoints Michael Woudenberg as Vice President, Chemistry, Manufacturing, and Controls November 5, 2018 Read More »
InMed Pharmaceuticals to Present at BIO Investor Forum on October 17, 2018 October 10, 2018 Read More »
InMed Pharmaceuticals Signs Agreement with the National Research Council of Canada for Cannabinoid Biofermentation Process Development and Scale-Up October 3, 2018 Read More »
InMed Pharmaceuticals Files PCT Patent Application for the Treatment of Pain with Cannabinoids September 25, 2018 Read More »
InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update September 13, 2018 Read More »
InMed Pharmaceuticals Announces NSERC Grant to The University of British Columbia in Support of Collaborative R&D Work September 11, 2018 Read More »
InMed Files Patent Application for its Cannabinoid Biosynthesis Program September 10, 2018 Read More »
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2018 Financial Results and Business Update on September 13, 2018 September 7, 2018 Read More »
InMed Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference August 31, 2018 Read More »
InMed Pharmaceuticals Announces the Closing of C$14.95 Million Bought Deal Financing including Full Exercise of Underwriter’s Over-Allotment Option June 21, 2018 Read More »
InMed Reports Third Quarter Fiscal 2018 Financial Results and Business Updates May 11, 2018 Read More »
